Well they could do a monthly investor webcast, but given they couldn't manage to broadcast the AGM because it was too hard...
In truth I think that their updates are normal in terms of just announcing milestones. Perhaps what you're getting at with Vivagel is that we would like to know the overall strategy. I'm assuming they will appoint the US distributor either just before or just after the FDA announcement as if it doesn't get approved then having a US distributor is suddenly irrelevant. I am also assuming that they want to launch in the US first and set the high pricing for prescription/insurance funded medicine there. In the last AGM it sounded as though they would get a high price (maybe $100 or more?) there. JF mentioned that people were paying high prices for the current solutions. Then they will launch worldwide. Obviously this is purely my speculation, but that's what you do when you have no info and a large investment .
SPL Price at posting:
$1.44 Sentiment: Buy Disclosure: Held
.
